格列本脲与治疗性低温对实验性心脏骤停后全球性脑水肿的减轻效果相当
该研究在小鼠心脏骤停/心肺复苏模型中,将7分钟心脏骤停的成年雄性C57Bl/6小鼠随机分为假手术组、常温对照组、常温格列本脲组、低温对照组和低温格列本脲组。主要结局为区域脑含水量,次要结局包括血糖、Sur1-TRPM4表达和促炎因子表达。结果显示,与常温相比,格列本脲或低温均显著降低脑含水量,但格列本脲联合低温无额外减轻脑水肿的作用。低温(而非格列本脲)部分抑制了促炎因子mRNA(TNF-α和IL-6)、NFκβ活化及SUR1-TRPM4的上调。作者认为格列本脲通过阻断Sur1-TRPM4通道减轻脑水肿,效果与治疗性低温相当,可作为心脏骤停后脑水肿的替代治疗选择。
要点
- 在7分钟心脏骤停/心肺复苏小鼠模型中,格列本脲治疗或治疗性低温均较常温显著减轻脑含水量。
- 格列本脲联合治疗性低温对减轻脑水肿无额外效果,提示两者作用可能重叠。
- 心脏骤停/心肺复苏后脑内TNF-α、IL-6 mRNA、NFκβ活化及SUR1-TRPM4水平上调。
- 治疗性低温(而非格列本脲)部分抑制上述促炎因子及SUR1-TRPM4的表达上调。
- 作者认为格列本脲是治疗心脏骤停诱发脑水肿的替代方法,效果与治疗性低温单用相当。
适用人群与场景
- 异氟烷麻醉的成年雄性野生型C57Bl/6小鼠,接受7分钟心脏骤停/心肺复苏。
- 研究分组包括:假手术组、常温对照组、常温格列本脲组、低温对照组、低温格列本脲组。
研究设计与关键结果
- 研究类型:实验性动物研究(小鼠心脏骤停/心肺复苏模型),随机分为五组:假手术、常温对照、常温格列本脲、低温对照、低温格列本脲。
- 主要结局:与常温相比,格列本脲治疗或低温均显著减轻心脏骤停/心肺复苏后小鼠的脑含水量。
- 格列本脲联合低温对减轻脑水肿无额外效果。
- 心脏骤停/心肺复苏后,促炎因子mRNA表达(TNF-α和IL-6)、NFκβ活化及SUR1-TRPM4水平上调。
- 与常温相比,低温(而非格列本脲)部分抑制上述促炎因子及SUR1-TRPM4的表达上调。
- 作者结论:格列本脲通过阻断心脏骤停后上调的Sur1-TRPM4通道减轻脑水肿,其效果与治疗性低温单用相当。
证据类型、等级与局限
- 证据类型:实验性动物研究(小鼠模型)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,格列本脲是治疗心脏骤停诱发脑水肿的替代方法,其效果与治疗性低温单用相当。
- 作者指出,格列本脲联合治疗性低温对减轻脑水肿无额外效果。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Cerebral edema is one of the major causes of mortality following cardiac arrest (CA) and cardiopulmonary resuscitation (CPR). A subunit of the sulfonylurea receptor 1-transient receptor potential M4 (Sur1-TRPM4) channel has been implicated in the pathogenesis of ischemia-evoked cerebral edema. In this study, we examined whether glibenclamide (GBC), a Sur1-TRPM4 channel inhibitor, attenuates cerebral edema following CA/CPR and further examined the efficacy of GBC combined with therapeutic hypothermia.
METHODS: Isoflurane-anesthetized adult male wild-type C57Bl/6 mice subjected to 7-min CA/CPR were randomized into five groups: sham operation, control with normothermia, GBC with normothermia, control with hypothermia, and GBC with hypothermia. The primary outcome was to evaluate regional brain water content; the secondary outcome was to measure blood glucose level, Sur1-TRPM4 expression, and pro-inflammatory factor expression.
RESULTS: Compared with normothermia, GBC treatment or hypothermia significantly attenuated brain water content in mice subjected to CA/CPR. GBC combined with hypothermia had no additional effects on attenuating cerebral edema. Pro-inflammatory factor messenger RNA expression (TNF-α and IL-6), NFκβ activation, and SUR1-TRPM4 levels were upregulated after CA/CPR. Compared with normothermia, hypothermia, but not GBC, partly suppressed these factors' expression.
CONCLUSIONS: GBC attenuated cerebral edema following CA/CPR by blocking Sur1-TRPM4 channels upregulated by CA insult. The effect of GBC was comparable with that of therapeutic hypothermia alone. These results suggest that GBC is an alternative approach for treating CA-evoked cerebral edema.
参考来源
- Nakayama S, Taguchi N, Isaka Y, et al. Glibenclamide and Therapeutic Hypothermia Have Comparable Effect on Attenuating Global Cerebral Edema Following Experimental Cardiac Arrest. Neurocrit Care. 2018. PMID: 29150777. doi:10.1007/s12028-017-0479-3
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。